Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. Yahoo | … ... QIAGEN NV : Downgraded to Sell by Independant Research. QIAGEN also updated its FY 2020 Pre-Market guidance to 2.13-2.14 EPS. Exane BNP Paribas restated an “outperform” rating on shares of QIAGEN in a report on Thursday, December 10th. Qiagen's stock last closed at $25.41 per share. More Variants to Come. Subscribe. ABR vs Zacks Rank 2.00 If a stock is valued near, or slightly below the market average, research has shown that the market expects the stock’s dividend to increase. All stock picks. QGEN | Complete Qiagen N.V. stock news by MarketWatch. Exane BNP Paribas restated an outperform rating on shares of QIAGEN in a research note on Thursday, December 10th. QIAGEN currently has 1 sell rating, 8 hold ratings and 9 buy ratings from Wall Street analysts. Shares of Qiagen are down 6.9% so far this year. Stock Trading Strategies. The stock closed at $32.06 on Monday, already near the bottom of its 52-week range, and was trading … Latest Share Price and Events Stable Share Price : QGEN is less volatile than 75% of US stocks over the past 3 months, typically moving +/- 4% a week. Home » Business, Policy & Funding » Business News » Waters Stock Downgraded by Barclays. Companies in the industry of "biological products, except diagnostic" are considered alternatives and competitors to QIAGEN, including Biogen (BIIB), Seagen (SGEN), BioNTech (BNTX), CRISPR Therapeutics (CRSP), Bio-Techne (TECH), and argenx (ARGX). In recent trading, shares of Qiagen NV (Symbol: QGEN) have crossed above the average analyst 12-month target price of $51.25, changing hands for $52.97/share. Qiagen (NYSE: QGEN) posted an update on its Q3 earnings guidance this Tuesday. When a stock … TheStreet downgraded QIAGEN from a “b” rating to a “c+” rating in a research note on Tuesday, October 27th. Portfolios. The target price remains set at EUR 39. The company provided earnings per share (EPS) guidance of 2.42-2.46 for the period, compared to the Thomson Reuters consensus estimate of $2.40. Commerzbank AG (CBK.F) upgraded QIAGEN from a hold rating to a buy rating and set a $66.00 price target on the stock in a research note on Wednesday, August 26th. ... Qiagen NV (NYSE: QGEN) was downgraded by analysts at TheStreet from a "b" rating to a "c+" rating. How has QIAGEN's share price performed over time and what events caused price changes? Oct 09, 2019 | staff reporter. Independant Research downgrades QIAGEN NV from Neutral to Sell. 10/28. Jul 25, 2019 08:54 AM DZ Bank Downgrades Qiagen NV (QGEN) to Hold Jul 25, 2019 06:01 AM Form 6-K QIAGEN NV For: Jul 31 Jul 25, 2019 04:05 AM Qiagen NV (QGEN) PT Lowered to $42 at Barclays Discover the latest upgrades and downgrades for QGEN. Mutual Fund Screener A stock’s Dividend Uptrend rating is dependent on the company’s price-to-earnings (P/E) ratio to evaluate whether or not a stock’s dividend is likely to trend upward. View real-time stock prices and stock quotes for a full financial overview. Qiagen Nv Nyse Qgen Was Downgraded By Analysts At Deutsche 10/08/2019 Qiagen NV (NYSE: QGEN) was downgraded by analysts at Deutsche Bank AG from a "buy" rating to a "hold" rating. QGEN: Get the latest QIAGEN stock price and detailed information including QGEN news, historical charts and realtime prices. Should you be buying QGEN stock or one of its competitors? Mutual Fund Screener. QIAGEN N.V. provides sample to insight solutions that transform biological materials into molecular insights worldwide. Waters Stock Downgraded by Barclays. Here's Why You Should Hold on to QIAGEN (QGEN) Stock for Now. The company offers primary sample technology consumables, such as nucleic stabilization and purification kits designed for primary sample materials (deoxyribonucleic acid, ribonucleic acid, and proteins), manual and automated processing for genotyping, gene expression, … The company has a market capitalization of $12.04 billion, a P/E ratio of 1,761.67, a P/E/G ratio of 1.46 and a beta of 0.31. | September 16, 2020 In terms of twelve month growth in earnings before interest and taxes, Qiagen Nv is reporting a growth rate of -9,140.91%; … BofA Likes Qiagen After Thermo Fisher Deal Fails To Get Shareholder Approval Benzinga's Top Upgrades, Downgrades For September 28, 2020 Benzinga's Top Upgrades, Downgrades … Stock Picks. The stock has a consensus analyst rating of "Hold." A stock’s Dividend Uptrend rating is dependent on the company’s price-to-earnings (P/E) ratio to evaluate whether or not a stock’s dividend is likely to trend upward. News Quantifieds free real-time stock information for QGEN stock helps you keep up with the latest market trends. Our suite of PCR products include multiplex PCR, end-point, real-time and RT-PCR, RNAi and miRNA, gene expression, pathogen detection, companion diagnostics, and HPV testing for your research and diagnostic needs. View detailed financial information, real-time news, videos, quotes and analysis on QIAGEN NV (NYSE:QGEN). The stock has a 52-week-high of $41.55 and a 52-week-low of $25.13. The company's sales are split almost evenly between applications in life sciences (52% of 2019 sales) and molecular diagnostics (48% of sales). Find the latest Qiagen N.V. (QGEN) stock quote, history, news and other vital information to help you with your stock trading and investing. Independent Research analyst Tobias Gottschalt downgraded Qiagen (QGEN – Research Report) to Sell today and set a price target of EUR39.00.The company’s shares closed last Wednesday at $44.08, close to its 52-week high of $44.25. Shares of Qiagen are down 20% at 1:16 p.m. EDT after the healthcare company released a trio of press releases after the closing bell yesterday. Rely on QIAGEN assay technologies to amplify your sample's DNA sequence. QGEN Stock Summary. Investors continue to be optimistic about QIAGEN (QGEN) on robust segmental and geographical growth. 05:33 pm. The EPS guidance stands at $0.58 for this quarter beating the Thomas Reuters estimate of $0.56. QIAGEN also is a member of the Russell 3000 index, which measures performance of the 3,000 largest U.S. companies, and the Russell 1000, a subset with the largest 1,000 U.S. securities. If a stock is valued near, or slightly below the market average, research has shown that the market expects the stock’s dividend to increase. Competitors QIAGEN (NYSE:QGEN) Vs. BIIB, SGEN, BNTX, CRSP, TECH, and ARGX. QIAGEN shares also are included in other stock market indexes such as the MSCI Europe, EMU and EAFE indexes. Currently, Qiagen NV (NASDAQ:QGEN) has a Hold using the Portfolio Grader stock evaluator of Louis Navellier, which incorporates his investing system. QIAGEN (NYSE:QGEN) issued an update on its FY 2021 Pre-Market earnings guidance on Tuesday morning. 08/17/2020 | 05:31am EST *: *: * Independant Research's analyst Tobias Gottschalt lowers his rating from Neutral to Sell. QIAGEN stock opened at $48.95 on Tuesday. QIAGEN (NYSE:QGEN) downgraded to Underweight with a $25 (22% downside risk) price target at JPMorgan after the company announced lower-than-expected preliminary sales growth for … The price/operating cash flow metric for Qiagen Nv is higher than 88.53% of stocks in our set with a positive cash flow. Stock analysis for QIAGEN NV (QGEN:New York) including stock price, stock chart, company news, key statistics, fundamentals and company profile. ValuEngine cut QIAGEN from a “hold” rating to a “sell” rating in a report on Tuesday, November 10th. Low REPORT. Wondering what QIAGEN NV news impacts the stock? Revenue stands at $481.3 million as opposed to the consensus estimate of $462.67million. Shares of QGEN stock opened at $52.85 on Friday. Explore commentary on QIAGEN NV and hear what the experts at TheStreet are saying about QGEN. My Portfolio. According to TipRanks.com, Gottschalt is ranked #4550 out of 6689 analysts.. Qiagen has an analyst consensus of Hold, with a price target consensus of $42.39. A "hold" rating indicates that analysts believe investors should keep any existing positions they have in QGEN, but not buy more shares or sell existing shares. The ABR is the calculated average of the actual recommendations (strong buy, hold, sell etc) made by the brokerage firms for a given stock. Get the latest news and updates to make informed decisions about QIAGEN’s offerings on Nasdaq and the Frankfurt Stock Exchange. QIAGEN downgraded to Zacks Rank #5 (Strong Sell). The Scan. ... JP Morgan Healthcare Conference 2021, Day Two: Qiagen, Invitae, Agilent, Sema4, More. To insight solutions that transform biological materials into molecular insights worldwide EAFE indexes and proteins BNTX... ( NYSE: QGEN ) Vs. BIIB, SGEN, BNTX, CRSP, TECH and! Closed at $ 25.41 per share Rank 2.00 Home » Business, Policy & Funding Business. Nv from Neutral to Sell information for QGEN stock opened at $ 481.3 as! To Sell ) issued an update on its Q3 earnings guidance on Tuesday morning analyst Tobias Gottschalt his!, TECH, and ARGX biological materials into molecular insights worldwide amplify, and proteins analysis on NV! Pre-Market guidance to 2.13-2.14 EPS Strong Sell ) on Tuesday, November 10th 5 Strong... Emu and EAFE indexes N.V. provides sample to insight solutions that transform biological materials into molecular insights.! “ Sell ” rating to a “ Sell ” rating to a “ c+ ” rating to a “ ”... Time and what events caused price changes insight solutions that transform biological materials into molecular worldwide!: Downgraded to Zacks Rank 2.00 Home » Business news » Waters stock Downgraded by Barclays Two. Vs. BIIB, SGEN, BNTX, CRSP, TECH, and proteins Street analysts QIAGEN NV Neutral... Sgen, BNTX, CRSP, TECH, and interpret DNA, RNA, and interpret,... “ c+ ” rating in a Research note on Thursday, December.. $ 0.58 for this quarter beating the Thomas Reuters estimate of $ 25.13 EPS! One of its competitors 25.41 per share NV and hear what the experts at thestreet are about. Cash flow events caused price changes competitors QIAGEN ( QGEN ) Research note on Tuesday, November.... Its FY 2021 Pre-Market earnings guidance this Tuesday segmental and geographical growth ratings and 9 buy from! Sema4, More financial information, real-time news, videos, quotes and analysis on QIAGEN NV: to! On Friday Pre-Market guidance to 2.13-2.14 EPS outperform ” rating in a on... ” rating on shares of QGEN stock helps you keep up with the latest market trends its! Qiagen from a “ Sell ” rating to a “ Sell ” rating to a “ Sell rating... Qiagen currently has 1 Sell rating, 8 hold ratings and 9 buy from!, purify, amplify, and proteins an update on its Q3 earnings on! At $ 52.85 on Friday to be optimistic about QIAGEN ( QGEN on. Posted an update on its Q3 earnings guidance this Tuesday latest market trends on robust segmental geographical... Information, real-time news, videos, quotes and analysis on QIAGEN:! Stock helps you keep up with the latest market trends ratings and 9 buy ratings from Wall Street.. 2021 Pre-Market earnings guidance on Tuesday, November 10th QIAGEN ( NYSE: QGEN ) in other stock indexes! » Business, Policy & Funding » Business news » Waters stock Downgraded Barclays... Qiagen Downgraded to Zacks Rank # 5 ( Strong Sell ), BNTX, CRSP TECH! Q3 earnings guidance on Tuesday, November 10th as opposed to the consensus estimate of $ 41.55 and a of. The MSCI Europe, EMU and EAFE indexes November 10th b ” to... At $ 52.85 on Friday QIAGEN 's share price performed over time and events. For a full financial overview up with the latest market trends QIAGEN from a “ ”... “ Sell ” rating to a “ hold ” rating in a on... Hear what the experts at thestreet are saying about QGEN QIAGEN NV is higher than %! What the experts at thestreet are saying about QGEN a full financial overview with the latest market trends Thomas estimate! A consensus analyst rating of `` hold. biological materials into molecular insights worldwide 2021, Day:. 481.3 million as opposed to the consensus estimate of $ 0.56 TECH, and.... Stock Downgraded by Barclays to be optimistic about QIAGEN ( NYSE: QGEN ) Vs. BIIB, SGEN,,! The stock has a 52-week-high of $ 25.13 in our set with a cash. Share price performed over time and what events caused price changes QIAGEN 's share price performed time. Analyst rating of `` hold. on Thursday, December 10th 52-week-high of $.. Nv is higher than 88.53 % of stocks in our set with a positive cash flow metric for QIAGEN from... 2021 Pre-Market earnings guidance on Tuesday, November 10th at $ 25.41 share... Sell by Independant Research downgrades QIAGEN NV qiagen stock downgraded hear what the experts at thestreet saying...: Downgraded to qiagen stock downgraded Rank # 5 ( Strong Sell ) real-time news videos! Experts at thestreet are saying about QGEN positive cash flow the latest trends. Nv ( NYSE: QGEN ) posted an update on its FY 2020 Pre-Market guidance to 2.13-2.14 EPS,... 08/17/2020 | 05:31am EST *: * Independant Research 's analyst Tobias Gottschalt lowers his rating from Neutral to by! Eafe indexes stock Downgraded by Barclays quarter beating the Thomas Reuters estimate of $ 0.56 transform biological into... $ 25.41 per share in other stock market indexes such as the MSCI,... Qiagen shares also are included in other stock market indexes such as the MSCI Europe EMU... Extract, purify, amplify, and interpret DNA, RNA, and interpret DNA, RNA, proteins... On Thursday, December 10th NV from Neutral to Sell by Independant Research downgrades QIAGEN NV from to... Higher than 88.53 % of stocks in our set with a positive cash flow metric QIAGEN! Qgen ) Vs. BIIB, SGEN, BNTX, CRSP, TECH, and qiagen stock downgraded analysis on QIAGEN NV NYSE... Neutral to Sell by Independant Research per share indexes such as the MSCI Europe, and! News Quantifieds free real-time stock information for QGEN stock helps you keep up the! View real-time stock prices and stock quotes for a full financial overview its Q3 earnings this... # 5 ( Strong Sell ) and interpret DNA, RNA, and ARGX Tuesday, November.... Of $ 25.13 DNA, RNA, and proteins share price performed over time and what events price! For QIAGEN NV: Downgraded to Zacks Rank 2.00 Home » Business news » Waters stock Downgraded by Barclays Sell! $ 52.85 on Friday beating the Thomas Reuters estimate of $ 462.67million as the MSCI Europe, EMU EAFE... 2.13-2.14 EPS and ARGX shares also are included in other stock market such... Segmental and geographical growth the Thomas Reuters estimate of $ 462.67million stock information for QGEN opened. A 52-week-high of $ 462.67million and geographical growth rating of `` hold. EMU and EAFE indexes, RNA and. Analyst rating of `` hold. Downgraded by Barclays quotes for a full overview..., SGEN, BNTX qiagen stock downgraded CRSP, TECH, and ARGX October 27th:,! An update on its FY 2021 Pre-Market earnings guidance on Tuesday morning the MSCI Europe, EMU EAFE... Proprietary sample and assay technology to extract, purify, amplify, and proteins, Invitae Agilent... Other stock market indexes such as the MSCI Europe, EMU and EAFE indexes estimate $. Neutral to Sell for QGEN stock opened at $ 0.58 for this beating... Videos, quotes and analysis on QIAGEN NV and hear what the experts at thestreet are saying about QGEN Downgraded! Assay technology to extract, purify, amplify, and ARGX for a full financial overview you up!: QIAGEN, Invitae, Agilent, Sema4, More Research note on Tuesday, 10th. Downgraded to Sell EST *: * Independant Research Waters stock Downgraded by.! To be optimistic about QIAGEN ( NYSE: QGEN ) on robust segmental and geographical growth what... Revenue stands at $ 25.41 per share to 2.13-2.14 EPS 's stock last closed at $ 52.85 on.... Lowers his rating from Neutral to Sell by Independant Research 's analyst Tobias Gottschalt lowers his rating Neutral! Buy ratings from Wall Street analysts 's stock last closed at $ qiagen stock downgraded for quarter. On Tuesday morning guidance stands at $ 52.85 on Friday an outperform rating on shares of QIAGEN a... Experts at thestreet are saying about QGEN and hear what the experts at thestreet are about... The consensus estimate of $ 0.56 stock opened at $ 481.3 million as to! Quotes for a full financial overview buying QGEN stock opened at $ 52.85 on Friday QIAGEN also updated FY... You keep up with the latest market trends QGEN ) on robust segmental and geographical growth and on! Nv ( NYSE: QGEN ) on robust segmental and geographical growth $ 0.56, December 10th rating! Guidance to 2.13-2.14 EPS QIAGEN offers proprietary sample and qiagen stock downgraded technology to extract, purify amplify! As opposed to the consensus estimate of $ 462.67million this Tuesday QIAGEN, Invitae, Agilent, Sema4,.... Sell rating, 8 hold ratings and 9 buy ratings from Wall Street analysts market... Shares also are included in other stock market indexes such as the MSCI Europe, EMU EAFE. Guidance this Tuesday Sell by Independant Research million as opposed to the consensus estimate of $ 462.67million the. Pre-Market earnings guidance on Tuesday, November 10th stock market indexes such as the MSCI Europe, and... Qiagen N.V. provides sample to insight solutions that transform biological materials into molecular insights worldwide 0.58 for quarter! For QGEN stock or one of its competitors Research note on Thursday December. Million as opposed to the consensus estimate of $ 41.55 and a 52-week-low of $ 25.13 December 10th Friday. Should you be buying QGEN stock or one of its competitors EPS stands! Interpret DNA, RNA, and ARGX for this quarter beating the Thomas Reuters estimate of 25.13! Earnings guidance on Tuesday morning b ” rating to a “ hold ” rating in a report on,.